Silihan lan utang jangka dawa perusahaan: Telomir Pharma (TELO)

The share price of Telomir Pharmaceuticals (TELO) visualized below is based on an outsourcing model where substance synthesis and testing are delegated to external contractors, and the indicator stands at 0.00. Process continuity is ensured through laboratory diversification and the express delivery of components. However, global conflicts and the severance of trade ties create risks, complicating raw material procurement and the conduct of international longevity research.

A comparative analysis of long-term liabilities allows for an assessment of the company's capital stability relative to systemic liquidity. This metric aggregates all creditor obligations with a maturity exceeding one year, determining financial leverage and overpayment risks during valuation. For Telomir Pharmaceuticals (TELO), this long-term financial debt figure is critical, as scaling anti-aging technologies requires significant investment prior to product commercialization.